Anthranilamide inhibitors of factor Xa

被引：18

作者：

Mendel, David ^{[1
]}

Marquart, Angela L. ^{[1
]}

Joseph, Sajan ^{[1
]}

Waid, Philip ^{[1
]}

Yee, Ying K. ^{[1
]}

Tebbe, Anne Louise ^{[1
]}

Ratz, Andrew M. ^{[1
]}

Herron, David K. ^{[1
]}

Goodson, Theodore ^{[1
]}

Masters, John J. ^{[1
]}

Franciskovich, Jeffry B. ^{[1
]}

Tinsley, Jennifer M. ^{[1
]}

Wiley, Michael R. ^{[1
]}

Weir, Leonard C. ^{[1
]}

Kyle, Jeffrey A. ^{[1
]}

Klimkowski, Valentine J. ^{[1
]}

Smith, Gerald F. ^{[1
]}

Towner, Richard D. ^{[1
]}

Froelich, Larry L. ^{[1
]}

Buben, John ^{[1
]}

Craft, Trelia J. ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 17期

关键词：

protease inhibitor; factor Xa; anticoagulant;

D O I：

10.1016/j.bmcl.2007.06.051

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR about the B-ring of a series of N-2-aroyl anthranilamide factor Xa (tXa) inhibitors is described. B-ring o-aminoalkylether and B-ring p-amine probes of the S1' and S4 sites, respectively, afforded picomolar fXa inhibitors that performed well in in vitro anticoagulation assays. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：4832 / 4836

页数：5

共 50 条

[21] Factor Xa inhibitors or factor IIa inhibitors in atrial fibrillation?
Cohen, Ariel
Ederhy, Stephane
Lang, Sylvie
Boyer-Chatenet, Louise
Dufaitre, Ghislaine
Meuleman, Catherine
Benamara, Sonia
Haddour, Nabila
Boccara, Franck
SANG THROMBOSE VAISSEAUX, 2013, 25 (01): : 19 - 33
[22] Factor Xa versus factor IIa inhibitors
Kaiser, B
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1997, 3 (01) : 16 - 24
[23] Qualitative and quantitative pharmacophore-similarity assessment of anthranilamide-based factor Xa inhibitors: applications on similar molecules with identical biological endpoints
Kumar, Sivakumar Prasanth
Rawal, Rakesh M.
Pandya, Himanshu A.
Jasrai, Yogesh T.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (02) : 189 - 206
[24] Reconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitors
Lu, G.
Luan, P.
Hollenbach, S. J.
Abe, K.
DeGuzman, F. R.
Siu, G.
Hutchaleelaha, A.
Inagaki, M.
Conley, P. B.
Phillips, D. R.
Sinha, U.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 309 - 309
[25] Heterogeneity of synthetic factor Xa inhibitors
Gerotziafas, GT
Samama, MM
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (30) : 3855 - 3876
[26] Phenyltriazolinones as potent factor Xa inhibitors
Quan, Mimi L.
Pinto, Donald J. P.
Rossi, Karen A.
Sheriff, Steven
Alexander, Richard S.
Amparo, Eugene
Kish, Kevin
Knabb, Robert M.
Luettgen, Joseph M.
Morin, Paul
Smallwood, Angela
Woerner, Francis J.
Wexler, Ruth R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (04) : 1373 - 1377
[27] Sulfonamidolactam inhibitors of coagulation factor Xa
Smallheer, Joanne M.
Wang, Shuaige
Laws, Mia L.
Nakajima, Suanne
Hu, Zilun
Han, Wei
Jacobson, Irina
Luettgen, Joseph M.
Rossi, Karen A.
Rendina, Alan R.
Knabb, Robert M.
Wexler, Ruth R.
Lam, Patrick Y. S.
Quan, Mimi L.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (07) : 2428 - 2433
[28] Isoxazolines and isoxazoles as Factor Xa inhibitors
Pruitt, JR
Pinto, DJ
Estrella, MJ
Bostrom, LL
Knabb, RM
Wong, PC
Wright, MR
Wexler, RR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (08) : 685 - 689
[29] Biphenylderivatives of benzamidine as Factor Xa inhibitors
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (05) : 717 - 721
[30] Progress in the discovery of Factor Xa inhibitors
Casimiro-Garcia, A
Dudley, DA
Heemstra, RJ
Filipski, KJ
Bigge, CF
Edmunds, JJ
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (02) : 119 - 145

← 1 2 3 4 5 →